Why More Women Over 35 Are Turning to Cannabis in 2026

The stoner stereotype died quietly sometime around 2024. Nobody held a funeral. The tie-dye and blacklight posters just got replaced by tincture bottles on nightstands and low-dose gummies tucked into handbags. And the people doing the replacing? Increasingly, they're women. Specifically, women over 35 who got tired of being told to try yoga, melatonin, or another glass of Pinot Noir.

The numbers back this up. According to a 2024 study published in Drug and Alcohol Dependence Reports, cannabis use among women aged 35 to 49 jumped from 14.25% to 17.23% between 2021 and 2022 alone. Female cannabis use overall climbed from 11.21% to 13.00% in the same window. That's a population-level shift, not a blip.

So what's actually driving this? And why now?

The Data Dump

The National Institute on Drug Abuse (NIDA) confirmed that cannabis use among adults aged 35 to 50 hit all-time highs in 2023. Past-year use in that group reached 29%. Past-month use sat at 19%. Daily use: 8%. These are record numbers for a demographic that, ten years ago, barely registered on the cannabis radar.

Among younger women (19 to 30), the gender gap flipped entirely. For the first time since the Monitoring the Future survey began tracking in 1975, female respondents in that age group reported higher past-year cannabis use than males. The generation behind them is already normalizing it, and the women in their late 30s and 40s are catching up fast.

A Reuters investigation in October 2024 reported that women now make up 55% of users on Jointly, a cannabis product discovery app with over half a million accounts. Female buyers at Housing Works Cannabis Co. in New York were outspending men per transaction. Dispensaries across the country told Reuters they were reorganizing shelf space toward products women tend to buy: edibles, topicals, tinctures, and beverages.

This tracks with broader industry data showing that 29% of female consumers prefer non-flower products, compared to 15% of men. Women are buying differently. 

Perimenopause Entered the Chat

Here's a fact that rarely gets airtime in the cannabis conversation: perimenopause can start as early as your mid-30s. Estrogen doesn't simply decline. It fluctuates wildly, sometimes spiking, sometimes crashing, taking sleep quality, mood stability, and temperature regulation along for the ride.

A Harvard Health article covered a survey published in the journal Menopause that studied 258 perimenopausal and postmenopausal women. Nearly 79% said they used cannabis to manage menopause-related symptoms. The top targets: sleep disturbance (67%) and mood or anxiety (46%). Perimenopausal women reported worse symptoms overall and higher rates of cannabis use to address them compared to postmenopausal participants.

The endocannabinoid system (ECS) plays a role here that deserves attention. The ECS helps regulate mood, sleep, pain signaling, inflammation, and temperature. Estrogen influences ECS function. When estrogen goes haywire during perimenopause, the ECS can become dysregulated too. This creates a biological environment where cannabinoids may offer genuine support, though clinical trials are still catching up to what millions of women are already experiencing firsthand.

A separate cross-sectional survey from Canada, published in BMC Women's Health, found that among women 35 and over using cannabis for menopause, 65% cited sleep difficulties, 45% cited anxiety, and 33% reported relief from muscle and joint aches. Most were using daily or more frequently, and nearly three-quarters called cannabis helpful for their symptoms.

These women aren't recreational users looking for a buzz. They're managing real, daily symptoms that traditional medicine has been slow to address with anything beyond hormone therapy and SSRIs.

The Alcohol Swap

Something else is happening alongside the cannabis trend: women are drinking less. The so-called "Cali Sober" movement, where people cut alcohol but keep cannabis, has gone from a niche California lifestyle to a mainstream option. Daily cannabis use now outpaces daily alcohol consumption for the first time in American history.

The appeal for women over 35 is pretty straightforward. Wine culture marketed itself hard to this demographic for years. The "mommy needs wine" era sold relaxation in a bottle and delivered headaches, weight gain, and worsening sleep architecture. A 5mg edible before bed doesn't come with a hangover, empty calories, or the 3 a.m. anxiety spiral that follows a couple of glasses of wine. For women navigating disrupted sleep, hormonal shifts, and the general chaos of midlife responsibilities, that trade-off makes practical sense.

Industry data supports this pattern. Research indicates that states with legal cannabis markets see measurable reductions in alcohol sales. A consumer survey found that 77% of THC beverage consumers have decreased their alcohol intake, and 21% have quit drinking entirely. Cannabis beverages, particularly low-dose options in the 2.5 to 5mg range, have become the fastest-growing product category in legal markets. Women are disproportionately driving that growth.

What Barney's Farm Knows About Growing for This Audience

At Barney's Farm, we've been breeding cannabis genetics since the 1980s. Our founder Derry spent years in the Himalayas collecting landrace seeds from Afghanistan, India, Nepal, Thailand, and beyond before establishing what would become one of the world's most awarded seed banks. We've won more Cannabis Cups than we can fit on one shelf. And we've watched the demographics of our customer base evolve dramatically.

The women buying seeds from Barney's Farm today know exactly what they want. They're looking for specific cannabinoid profiles, predictable effects, and strains they can grow with confidence. Many are first-time growers who want control over what they consume: no pesticides, no mystery additives, no supply chain between them and their plant.

Our feminized seed collection was designed with this kind of intentional grower in mind. Feminized seeds eliminate the guesswork of identifying and removing male plants, which means a streamlined growing experience from seed to harvest. For someone managing perimenopause symptoms who wants a reliable indica-dominant strain for sleep, or a balanced hybrid for daytime anxiety, the genetics matter. Strains like Cookies Kush deliver deep physical relaxation. Tangerine Dream, a Cannabis Cup winner, offers a brighter, more uplifting profile that many women prefer during the day. For those interested in CBD-rich options, CBD Blue Shark provides therapeutic potential without heavy psychoactive effects.

Our breeding programs have always prioritized terpene profiles alongside THC and CBD content. Terpenes influence the experience significantly, and we believe informed consumers, especially women approaching cannabis with specific wellness goals, deserve genetics that deliver consistent results. That's what decades of stabilizing phenotypes and back-crossing genetics gives you. Not a gamble on every harvest. A reliable outcome.

The Culture Shift Nobody Predicted

Ten years ago, the cannabis industry looked like it was built by men, for men. The branding was loud. The products were one-dimensional: high THC, bigger hit, stronger buzz. The marketing assumed every consumer was chasing the same experience.

Women changed that. They asked for lower doses. They wanted formats that fit into a nighttime routine, not a party. They demanded ingredient transparency and lab-tested products. Edibles went from novelty to the second most popular product format because women preferred them. Topicals exist as a mainstream category because women drove the demand. Cannabis beverages scaled up because women wanted an alternative to wine, not a replacement for a joint.

This consumer behavior reshaped the entire supply chain. Retailers adjusted inventory. Brands redesigned packaging. Product developers created formulations targeting sleep, pain, recovery, and stress, the exact symptoms women over 35 were managing. The $30 billion U.S. cannabis industry pivoted because women showed up and spent money with intention.

And women aren't passive consumers in this space. They make up roughly 40% of executive positions in the cannabis industry, a higher percentage than most other sectors. Female-founded brands are growing across the market, and women-led companies like Gal Pals Minis, Kikoko, and Neno's Naturals are building products based on their own lived experiences with pain, hormonal shifts, and stress.

What Women Are Actually Searching For

The search data tells its own story. Queries for "cannabis for women over 35" and "women using weed 2026" have increased alongside terms like "cannabis for perimenopause," "weed for sleep anxiety," and "mom cannabis trend." These searches reflect a consumer who does research before she buys. She reads lab results. She compares strain profiles. She wants to know exactly what 5mg of THC in an edible will feel like at 10 p.m. on a Tuesday.

This is an informed, deliberate consumer. She's not interested in stoner culture. She's interested in function. And the cannabis industry, including seed banks like Barney's Farm, needs to meet her where she is: with transparent information, reliable genetics, and products that respect the specificity of what she's looking for.

Barney's Farm has been developing premium cannabis genetics since the 1980s, with over 40 Cannabis Cup wins. Explore our full seed catalog and find strains bred for every climate and skill level.